These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21969078)

  • 1. Developing treatment strategies for rare cancers.
    Atkinson JM; Gilbertson RJ
    Oncotarget; 2011 Sep; 2(9):657. PubMed ID: 21969078
    [No Abstract]   [Full Text] [Related]  

  • 2. Should clinical trials be approached differently for rare cancers?
    Olver I
    Future Oncol; 2016 May; 12(10):1207-9. PubMed ID: 26939845
    [No Abstract]   [Full Text] [Related]  

  • 3. International rare cancers initiative.
    Keat N; Law K; Seymour M; Welch J; Trimble T; Lascombe D; Negrouk A
    Lancet Oncol; 2013 Feb; 14(2):109-10. PubMed ID: 23369681
    [No Abstract]   [Full Text] [Related]  

  • 4. Trials and tribulations: improving outcomes for adolescents and young adults with rare and low survival cancers.
    Walczak A; Patterson P; Thomas D
    Med J Aust; 2018 Oct; 209(8):330-332. PubMed ID: 30309304
    [No Abstract]   [Full Text] [Related]  

  • 5. The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers.
    Schott AF; Welch JJ; Verschraegen CF; Kurzrock R
    Semin Oncol; 2015 Oct; 42(5):731-9. PubMed ID: 26433554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need randomised trials for rare cancers?
    Prasad V; Oseran A
    Eur J Cancer; 2015 Jul; 51(11):1355-7. PubMed ID: 25963018
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial design for rare cancers: why a less conventional route may be required.
    Panageas KS
    Expert Rev Clin Pharmacol; 2015; 8(6):661-3. PubMed ID: 26517109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for randomised clinical trials in rare cancers.
    Tan SB; Dear KB; Bruzzi P; Machin D
    BMJ; 2003 Jul; 327(7405):47-9. PubMed ID: 12842959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 10. Children's Oncology Group's 2013 blueprint for research: rare tumors.
    Rodriguez-Galindo C; Krailo M; Frazier L; Chintagumpala M; Amatruda J; Katzenstein H; Malogolowkin M; Spector L; Pashankar F; Meyers R; Tomlinson G;
    Pediatr Blood Cancer; 2013 Jun; 60(6):1016-21. PubMed ID: 23255219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research methods to change clinical practice for patients with rare cancers.
    Billingham L; Malottki K; Steven N
    Lancet Oncol; 2016 Feb; 17(2):e70-e80. PubMed ID: 26868356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized teams or specialist networks for rare cancers?
    Sandrucci S; Gatta G; Trama A; Dei Tos AP; Casali PG
    Eur J Surg Oncol; 2015 Sep; 41(9):1115-7. PubMed ID: 25936223
    [No Abstract]   [Full Text] [Related]  

  • 13. How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.
    Park JH; Lee JS; Koo H; Kim JE; Ahn JH; Ryu MH; Park SR; Yoon SK; Lee JC; Hong YS; Kim SY; Kim KP; Yoo CH; Hong JY; Lee JL; Jung KH; Rhyoo BY; Kim TW
    J Cancer Educ; 2020 Jun; 35(3):545-556. PubMed ID: 30820925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Special issue on rare cancers.
    Sandler A; Reilly K; Widemann B
    Curr Probl Cancer; 2021 Aug; 45(4):100774. PubMed ID: 34304884
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
    Bogaerts J; Sydes MR; Keat N; McConnell A; Benson A; Ho A; Roth A; Fortpied C; Eng C; Peckitt C; Coens C; Pettaway C; Arnold D; Hall E; Marshall E; Sclafani F; Hatcher H; Earl H; Ray-Coquard I; Paul J; Blay JY; Whelan J; Panageas K; Wheatley K; Harrington K; Licitra L; Billingham L; Hensley M; McCabe M; Patel PM; Carvajal R; Wilson R; Glynne-Jones R; McWilliams R; Leyvraz S; Rao S; Nicholson S; Filiaci V; Negrouk A; Lacombe D; Dupont E; Pauporté I; Welch JJ; Law K; Trimble T; Seymour M
    Eur J Cancer; 2015 Feb; 51(3):271-81. PubMed ID: 25542058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare cancers: the greatest inequality in cancer research and oncology treatment.
    Alvi MA; Wilson RH; Salto-Tellez M
    Br J Cancer; 2017 Oct; 117(9):1255-1257. PubMed ID: 28934760
    [No Abstract]   [Full Text] [Related]  

  • 17. Collaboration is key to treating uncommon cancers: scientists and patients champion research in these rare diseases.
    Printz C
    Cancer; 2010 Jun; 116(12):2847-9. PubMed ID: 20564387
    [No Abstract]   [Full Text] [Related]  

  • 18. Rare cancers: A network for better care.
    Sandrucci S; Gatta G
    Eur J Surg Oncol; 2019 Jan; 45(1):1-2. PubMed ID: 30041942
    [No Abstract]   [Full Text] [Related]  

  • 19. "People with rare cancers get a raw deal in research and care".
    Newlands J
    Nurs Times; 2012 Feb 7-13; 108(6):11. PubMed ID: 22720483
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of research collaborations and consortia in rare cancers.
    Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
    Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.